BNP Paribas is aiming to acquire the remaining 50% stake in Exane, the investment firm it already part owns, in a major play to grab a bigger share of the equities market as European rivals scale back.
The French bank is pushing to expand into the stock trading, and the acquisition would bolster its position in both cash and equity derivatives, it said in a statement announcing the deal.
